Diet or optimised medical therapy for people with irritable bowel syndrome

Affiliations

¹ Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy; National Institute for Health and Care Research Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK. Electronic address: christian.lambiase@phd.unipi.it.
² Center for Functional Gastrointestinal and Motility Disorders, University of North Carolina, Chapel Hill, NC, USA; Il Cerchio Med HealthCare, Verona, Italy.
³ Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy.

Comment

Christian Lambiase et al. Lancet Gastroenterol Hepatol. 2024 Sep.

. 2024 Sep;9(9):785-786.

doi: 10.1016/S2468-1253(24)00194-8.

¹ Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy; National Institute for Health and Care Research Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK. Electronic address: christian.lambiase@phd.unipi.it.
² Center for Functional Gastrointestinal and Motility Disorders, University of North Carolina, Chapel Hill, NC, USA; Il Cerchio Med HealthCare, Verona, Italy.
³ Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy.

No abstract available

Conflict of interest statement

We declare no competing interests.

Diet or optimised medical therapy for people with irritable bowel syndrome - Authors' reply.
Nybacka S, Törnblom H, Josefsson A, Hreinsson JP, Böhn L, Frändemark Å, Weznaver C, Störsrud S, Simrén M. Nybacka S, et al. Lancet Gastroenterol Hepatol. 2024 Sep;9(9):786-787. doi: 10.1016/S2468-1253(24)00219-X. Lancet Gastroenterol Hepatol. 2024. PMID: 39127072 No abstract available.

A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.
Nybacka S, Törnblom H, Josefsson A, Hreinsson JP, Böhn L, Frändemark Å, Weznaver C, Störsrud S, Simrén M. Nybacka S, et al. Lancet Gastroenterol Hepatol. 2024 Jun;9(6):507-520. doi: 10.1016/S2468-1253(24)00045-1. Epub 2024 Apr 18. Lancet Gastroenterol Hepatol. 2024. PMID: 38643782 Clinical Trial.